Market Tracker

08/30 5:16pm ET

Depomed Inc (NASDAQ:DEPO)

20.05
Delayed Data
As of Aug 30
 +0.54 / +2.77%
Today’s Change
12.25
Today|||52-Week Range
29.44
+10.59%
Year-to-Date
Drugmakers hooked on $10bn opioid habit
Aug 10 / FT.com - Paid Partner Content
 

Today’s Trading

Previous close19.51
Today’s open19.30
Day’s range19.30 - 20.13
Volume827,467
Average volume (3 months)1,293,512
Market cap$1.2B
Dividend yield--
Data as of 4:00pm ET, 08/30/2016

Growth & Valuation

Earnings growth (last year)-161.46%
Earnings growth (this year)+72.40%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)-12.20%
P/E ratioNM
Price/Sales3.18
Price/Book3.76

Competitors

 Today’s
change
Today’s
% change
INVAInnoviva Inc+0.05+0.46%
SAGESAGE Therapeutics In...-0.52-1.35%
LCILannett Company Inc-0.62-1.83%
PTLAPortola Pharmaceutic...+0.21+1.03%
Data as of 4:01pm ET, 08/30/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$0.37
Annual revenue (last year)$342.7M
Annual profit (last year)-$75.7M
Net profit margin-22.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
CFO, Senior VP &
Head-Investor Relations
August J. Moretti
Corporate headquarters
Newark, California

Forecasts